Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Hypertension
Sustained BP elevation of 140/90 or greater
PIH
Gestasional
Preeclampsia
Chronic
Mild
Severe
HELLP
Synd
Effect
Impending
eclampsia
Eclampsia
20
Proteinuria (-)
Proteinuria (+)
Preeklampsia
Hipertensi kronik
Hipertensi Gestasional
Proteinuria (+)
Super imposed
Gestational Hypertension
Criteria
Develops after 20 weeks of gestation
Proteinuria is absent
Blood pressures return to normal postpartum
Overlap/Disease Progression
P a t i e n t w it h H y p e r t e n s i o n
E le v a te d B P a b o v e
f ir s t t r im e s t e r
l e v e ls
5 5 -7 5 %
G e s t a t io n a l h y p e r t e n s io n
N o p r o t e i n u r ia
5 - 1 0 % o f s in g l e t o n s 25%
3 0 % o f m u lt ip le s
5 -8
P r e e c la m p s ia
H y p e r te n s io n
P r o t e i n u r ia
% o f p r o g n a n c ie s
Preeclampsia
Criteria
Develops after 20 weeks
Blood pressure elevated on two occasions at least 6 hours apart
Associated with proteinuria and edema
May occur less than 20 weeks with gestational trophoblastic
neoplasia
Eclampsia
HELLP Syndrome
Eclampsia
Diagnosis of preeclampsia
Presence of convulsions not explained by a neurologic
disorder
Grand mal seizure activity
HELLP Syndrome
A distinct clinical entity with:
Hemolysis, Elevated Liver enzymes, Low Platelets
Mississippi Classification:
Class 1 : Platelet count : <= 50.000 / ml
LDH >= 600 IU / l
AST and/or ALT >= 40 IU / l
Class 2 : Platelet count : >50.000 <= 100.000 / ml
LDH >= 600 IU / l
AST and/or ALT >= 40 IU / l
Class 3 : Platelet count : >100.000 <= 150.000 / ml
LDH >= 600 IU / l
AST and/or ALT >= 40 IU / l
Pathophysiology
Vasospasm
Uterine vessels
Hemostasis
Prostanoid balance
Endothelium-derived factors
Lipid peroxide, free radicals and antioxidants
Pathophysiology
Vasospasm
Predominant finding in gestational hypertension and
preeclampsia
Uterine vessels
Hemostasis
Prostanoid balance
Endothelium-derived factors
Lipid peroxide, free radicals and antioxidants
Pathophysiology
Vasospasm
Uterine vessels
Inadequate maternal vascular response to trophoblastic
mediated vascular changes
Endothelial damage
Hemostasis
Prostanoid balance
Endothelium-derived factors
Lipid peroxide, free radicals and antioxidants
Pathophysiology
Vasospasm
Uterine vessels
Hemostasis
Increase platelet activation resulting in consumption
Increased endothelial fibronectin levels
Decreased antithrombin III and 2-antiplasmin levels
Allows for microthrombi development with resultant
increase in endothelial damage
Prostanoid balance
Endothelium-derived factors
Lipid peroxide, free radicals and antioxidants
Pathophysiology
Vasospasm
Uterine vessels
Hemostasis
Prostanoid balance
Prostacyclin (PGI2):Thromboxane (TXA2) balance shifted to favor
TXA2
TXA2 promotes:
Vasoconstriction
Platelet aggregation
Endothelium-derived factors
Lipid peroxide, free radicals and antioxidants
Pathophysiology
Vasospasm
Uterine vessels
Hemostasis
Prostanoid balance
Endothelium-derived factors
Nitric oxide is decreased in patients with preeclampsia
As this is a vasodilator, this may result in vasoconstriction
Lipid peroxide, free radicals and antioxidants
Pathophysiology
Vasospasm
Uterine vessels
Hemostasis
Prostanoid balance
Endothelium-derived factors
Pathophysiologic Changes
Cardiovascular effects
Hematologic effects
Neurologic effects
Pulmonary effects
Renal effects
Fetal effects
Pathophysiologic Changes
Cardiovascular effects
Hypertension
Increased cardiac output
Increased systemic vascular resistance
Hematologic effects
Neurologic effects
Pulmonary effects
Renal effects
Fetal effects
Pathophysiologic Changes
Cardiovascular effects
Hematologic effects
Volume contraction/Hypovolemia
Elevated hematocrit
Thrombocytopeniz
Microangiopathic hemolytic anemia
Third spacing of fluid
Low oncotic pressure
Neurologic effects
Pulmonary effects
Renal effects
Fetal effects
Pathophysiologic Changes
Cardiovascular effects
Hematologic effects
Neurologic effects
Hyperreflexia
Headache
Cerebral edema
Seizures
Pulmonary effects
Renal effects
Fetal effects
Pathophysiologic Changes
Cardiovascular effects
Hematologic effects
Neurologic effects
Pulmonary effects
Capillary leak
Reduced colloid osmotic pressure
Pulmonary edema
Renal effects
Fetal effects
Pathophysiologic Changes
Cardiovascular effects
Hematologic effects
Neurologic effects
Pulmonary effects
Renal effects
Fetal effects
Renal Effects
Decreased glomerular filtration rate
Glomerular endotheliosis
Proteinuria
Oliguria
Acute tubular necrosis
Pathophysiologic Changes
Cardiovascular effects
Hematologic effects
Neurologic effects
Pulmonary effects
Renal effects
Fetal effects
Placental abruption
Fetal growth restriction
Oligohydramnios
Fetal distress
Increased perinatal morbidity and mortality
Management
The ultimate cure is delivery
Assess gestational age
Assess cervix
Fetal well-being
Laboratory assessment
Rule out severe disease!!
Unfavorable Cervix
No contraindication to prostaglandin agents
If < 32 weeks, consider cesarean
When favorable, oxytocin
Hypertensive Emergencies
Fetal monitoring
IV access
IV hydration
The reason to treat is maternal, not fetal
May require ICU
Hydralazine
Dose: 5-10 mg every 20 minutes
Onset: 10-20 minutes
Duration: 3-8 hours
Side effects: headache, flushing, tachycardia,
lupus like symptoms
Mechanism: peripheral vasodilator
Labetalol
Dose: 20mg, then 40, then 80 every 20 minutes,
for a total of 220mg
Onset: 1-2 minutes
Duration: 6-16 hours
Side effects: hypotension
Mechanism: Alpha and Beta block
Nifedipine
Dose: 10 mg po, not sublingual
Onset: 5-10 minutes
Duration: 4-8 hours
Side effects: chest pain, headache, tachycardia
Mechanism: CA channel block
Clonidine
Dose: 1 mg po
Onset: 10-20 minutes
Duration: 4-6 hours
Side effects: unpredictable, avoid rapid withdrawal
Mechanism: Alpha agonist, works centrally
Nitroprusside
Dose: 0.2 0.8 mg/min IV
Onset: 1-2 minutes
Duration: 3-5 minutes
Side effects: cyanide accumulation, hypotension
Mechanism: direct vasodilator
Seizure Prophylaxis
Magnesium sulfate
4-6 g bolus
1-2 g/hour
Monitor urine output and DTRs
With renal dysfunction, may require a lower dose
Magnesium Sulfate
Is not a hypotensive agent
Works as a centrally acting anticonvulsant
Also blocks neuromuscular conduction
Serum levels: 6-8 mg/dL
Toxicity
Respiratory rate < 12
DTRs not detectable
Altered sensorium
Urine output < 25-30 cc/hour
Antidote: 10 ml of 10% solution of calcium
gluconate 1 v over 3 minutes
Treatment of Eclampsia
Few people die of seizures
Protect patient
Avoid insertion of airways and padded tongue
blades
IV access
MGSO4 4-6 bolus, if not effective, give another 2 g
Alternate Anticonvulsants
Have not been shown to be as efficacious as
magnesium sulfate and may result in sedation
that makes evaluation of the patient more difficult
Diazepam 5-10 mg IV
Sodium Amytal 100 mg IV
Pentobarbital 125 mg IV
Dilantin 500-1000 mg IV infusion
Other Complications
Pulmonary edema
Oliguria
Persistent hypertension
DIC
Pulmonary Edema
Fluid overload
Reduced colloid osmotic pressure
Occurs more commonly following delivery as
colloid oncotic pressure drops further and fluid is
mobilized
Oliguria
25-30 cc per hour is acceptable
If less, small fluid boluses of 250-500 cc as needed
Lasix is not necessary
Postpartum diuresis is common
Persistent oliguria almost never requires a PA cath
Persistent Hypertension
BP may remain elevated for several days
Diastolic BP less than 100 do not require
treatment
By definition, preeclampsia resolves by 6 weeks
Anesthesia Issues
Continuous lumbar epidural is preferred if
platelets normal
Need adequate pre-hydration of 1000 cc
Level should always be advanced slowly to avoid
low BP
Avoid spinal with severe disease
HELLP Syndrome
He-hemolysis
EL-elevated liver enzymes
LP-low platelets
HELLP Syndrome
Is a variant of severe preeclampsia
Platelets < 100,000
LFTs - 2 x normal
May occur against a background of what appears
to be mild disease
Conservative Management
Controversial
Steroids
Requires tertiary care
Must have stable labs and reassuring fetal status
May use antihypertensives
Prevention
Low dose ASA ineffective in patients at
low risk
Recent study done with antioxidant
(1,000mg VitC and 400mg VitE).
Small study that needs to be confirmed.